Astrocyte Pharmaceuticals Inc logo

Astrocyte Pharmaceuticals Inc.

Astrocyte Pharmaceuticals is a small drug development company dedicated to clinically proving the neuroprotective benefits of selective astrocyte activation, and advancing breakthrough therapeutic agents for treating brain injury patients.

0
Management
0
Technology
0
Deals/Partnering
0
Research Pipeline
0
Funding
BioStartup's Score 0 / 50

KEY DETAILS

Websitehttps://www.astrocytepharma.com
Founded2014
Disease Focus
Development Stage
STOCK CODENon Listed
Address
245 First Street; Suite 1800, MA 02142
Cambridge
United States
Email
Contact Number
+1 617 444 8765

[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=” ” connections=”true” suffix=””]

In july 2017, Astrocyte Pharmaceuticals Completes $2.4M Seed Financing Round, led by Boston Harbor Angels, and joined by the University of Texas Horizon Fund, SideCar Angels and others. Joining in the subsequent closing were the Mass Medical Angels, Zhi Gao Holding Ltd., Nest.Bio Ventures and additional investors.

March 2017, Astrocyte Pharmaceuticals Raises Over $1.3M in Seed Financing Round led by Boston Harbor Angels, and joined by the University of Texas Horizon Fund, SideCar Angels and others.